Indomethacin-Induced Apoptosis in Esophageal Adenocarcinoma Cells Involves Upregulation of Bax and Translocation of Mitochondrial Cytochrome C Independent of COX-2 Expression

by Sanjeev Aggarwal, Neelam Taneja, Lin Lin, Mark B. Orringer, Alnawaz Rehemtulla, David G. Beer
Published 2000-07-01

Cytochromes P450 are Expressed in Proliferating Cells in Barrett's Metaplasia

by Steven J. Hughes, Mark A. Morse, Christopher M. Weghorst, Hyesook Kim, Paul B. Watkins, F. Peter Guengerich, Mark B. Orringer, David G. Beer
Published 1999-06-01

L-Type Amino Acid Transporter-1 Overexpression and Melphalan Sensitivity in Barrett's Adenocarcinoma

by Jules Lin, Duna A. Raoof, Dafydd G. Thomas, Joel K. Greenson, Thomas J. Giordano, Gregory S. Robinson, Maureen J. Bourner, Christopher T. Bauer, Mark B. Orringer, David G. Beer
Published 2004-01-01

Upregulated INHBA Expression May Promote Cell Proliferation and Is Associated with Poor Survival in Lung Adenocarcinoma

by Christopher W. Seder, Wibisono Hartojo, Lin Lin, Amy L. Silvers, Zhuwen Wang, Dafydd G. Thomas, Thomas J. Giordano, Guoan Chen, Andrew C. Chang, Mark B. Orringer, David G. Beer
Published 2009-04-01

Expression and Effect of Inhibition of the Ubiquitin-Conjugating Enzyme E2C on Esophageal Adenocarcinoma

by Jules Lin, Duna A. Raoof, Zhuwen Wang, Mu-Yen Lin, Dafydd G. Thomas, Joel K. Greenson, Thomas J. Giordano, Mark B. Orringer, Andrew C. Chang, David G. Beer, Lin Lin
Published 2006-12-01

18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.

by Brendan T Heiden, Guoan Chen, Matthew Hermann, Richard K J Brown, Mark B Orringer, Jules Lin, Andrew C Chang, Philip W Carrott, William R Lynch, Lili Zhao, David G Beer, Rishindra M Reddy
Published 2018-01-01

Proteomic Analysis of Cytokeratin Isoforms Uncovers Association with Survival in Lung Adenocarcinoma

by Tarek G. Gharib, Guoan Chen, Hong Wang, Chiang-Ching Huang, Michael S. Prescott, Kerby Shedden, David E. Misek, Dafydd G. Thomas, Thomas J. Giordano, Jeremy M.G. Taylor, Sharon Kardiat, John Yee, Mark B. Orringer, Samir Hanash, David G. Beer
Published 2002-01-01

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

by Stuart E. Samuels, MD, PhD, Matthew H. Stenmark, MD, Jae Y. Lee, MD, PhD, Jonathan B. McHugh, MD, James A. Hayman, MD, Mark B. Orringer, MD, Susan G. Urba, MD, Libin Sun, MD, Congying Xie, PhD, Feng-Ming Kong, MD, PhD, Kyle C. Cuneo, MD
Published 2017-07-01